Home / Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated / Canada
CA ATC J07AH08 · updated 2 Nov 2026
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated shortage in Canada
Is there a Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated shortage in Canada?
Yes. As of 2 Nov 2026, 1 Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated product is reported short in Canada. No return date has been given. Main reason: not stated.
Also short in Italy, Czechia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MENACTRA (5 x 0.5 mL vials) discontinuation | SANOFI PASTEUR LIMITED | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.